IMB receives $13.2 million in medical research funding

17 Oct 2011

Researchers from the Institute for Molecular Bioscience have received $13.2 million in fellowships and grants from the National Health and Medical Research Council (NHMRC) to investigate diseases ranging from chronic pain to brain tumours to antibiotic-resistant infections.

These formed part of The University of Queensland's total of $49.47 million in grants and fellowships, one of the largest shares of funding awarded to institutions across Australia.

The IMB received a total of 18 grants to 13 investigators, including four grants totalling nearly $2 million to Professor Mike Waters, and five of UQ's seven fellowships.

Deputy Vice-Chancellor (Research) Professor Max Lu congratulated the recipients and thanked the NHMRC for its continued support of Australian medical research. 

"Breakthroughs in the prevention, cure and management of diseases and disabilities only come through rigorous and focused research," Professor Lu said. 

"The successful UQ projects range from investigating ways to boost the human immune system to improving treatments for childhood burns and seeking a better understanding cerebral palsy.” 

"I thank our researchers for the dedication and skills they bring to addressing such a diversity of health and medical problems that currently reduce quality of life and life expectancy.”

IMB's successful Fellows are Professors Mike Waters, David Craik, David Fairlie, Sean Grimmond and Richard Lewis.

IMB's project grants were awarded to: Professors Matt Cooper, David Craik, David Fairlie, Glenn King, George Muscat, Brandon Wainwright, Mike Waters and Mark Ragan, Associate Professors Andrew Perkins and Rick Sturms, and Drs Jo Bowles, Kate Schroder and Matt Sweet.

Media: Fiona Cameron, UQ Communications (07 3346 7086, 0407 113 342) or Bronwyn Adams, IMB Communications (07 3346 2134 or 0418 575 247)